Page last updated: 2024-08-17

methylene blue and Parkinsonian Disorders

methylene blue has been researched along with Parkinsonian Disorders in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Biondo, E; Clark, ME; Cormack, LK; Gonzalez-Lima, F; Hardy, GA; Kraan, DJ; Lee, HJ; Monfils, M; Smith, ES1
Biju, KC; Carlisle, DCB; Clark, RA; Evans, RC; Gelfond, J; Shrestha, K1

Other Studies

2 other study(ies) available for methylene blue and Parkinsonian Disorders

ArticleYear
Daily consumption of methylene blue reduces attentional deficits and dopamine reduction in a 6-OHDA model of Parkinson's disease.
    Neuroscience, 2017, 09-17, Volume: 359

    Topics: Animals; Antioxidants; Attention; Behavior, Animal; Dopamine; Dopaminergic Neurons; Male; Methylene Blue; Neuroprotective Agents; Parkinsonian Disorders; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area

2017
Methylene Blue Ameliorates Olfactory Dysfunction and Motor Deficits in a Chronic MPTP/Probenecid Mouse Model of Parkinson's Disease.
    Neuroscience, 2018, 06-01, Volume: 380

    Topics: Animals; Antioxidants; Behavior, Animal; Brain; Dopaminergic Neurons; Male; Methylene Blue; Mice; Mice, Inbred C57BL; Motor Activity; Neuroprotective Agents; Parkinsonian Disorders; Smell

2018